Letters to the Editor

Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial

Dept. of Medicine I Hematology and Oncology, Medical Center - University of Freiburg, Germany;
Dept. of Medicine I Hematology, Oncology, CCCF, Medical Center - University of Freiburg, Germany;
Clinical Trials Unit, University of Freiburg Medical Center, Freiburg, Germany;
Hematology, Oncology and Rheumatology, University of Ulm Medical Center, Ulm, Germany;
Hematology and Oncology, University of Leipzig Medical Center, Leipzig, Germany;
University of Jena Medical Center and Heinrich-Braun-Klinikum Zwickau, Würzburg, Germany;
Hematology and Oncology, University of Würzburg Medical Center, Würzburg, Germany;
Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
Medical Center - University of Freiburg and Comprehensive Cancer Center, Freiburg, Germany
Haematologica Early view May 15, 2020 https://doi.org/10.3324/haematol.2020.254235